NMT reports consulting or advisory roles with Oncorena, Merck Sharp & Dohme, Bristol Myers Squibb (BMS) Foundation, and Nektar; stock ownership with AbbVie, Amgen, Arcturus, Arcus Biosciences, AstraZeneca, BioCryst Pharmaceutical, Coherus BioSciences, Corvus Pharmaceuticals, CVS Health, Gilead Science...
NMT reports research funding from BMS, Calithera Biosciences, Nektar Therapeutics, Exelixis, Pfizer, Novartis, Arrowhead Pharmaceuticals, Mirati Therapeutics, Takeda, Epizyme and Eisai Medical Research; consulting and advisory fees from BMS, Calithera Biosciences, Nektar Therapeutics, Exelixis, Pfizer, ...
differing onset types have been classified as motion-triggered (MT) and non-motion-triggered (NMT) MdDS, respectively [3,4,5,11,12]. The MdDS clinical population demonstrates a female/male ratio of between 8:2 and 9:1 [4,5,8,10,13]. In females, the age of MdDS onset is commonly...
ratilol nFiosfhpera'rstiecxipaactnttseswtshpoeerxfhoirbmiteedd orenlitahbeleRcChaI ndgee- fterorimoraptrieo-ntdoaptaoswt-etrreeantmone-nsitgansisfiecsasnmt;ehnot.wAevllerF,itshheerF'issheexra'cstetxeasctst tpeestrfpo-rvmaleude ofonr tdheepRreCsI- ismiopnroavpepmroeancthdeadtaswigenrie...